Fallopian TubesFallopian Tube NeoplasmsOvarian NeoplasmsFallopian Tube DiseasesFallopian Tube Patency TestsNeoplasms, Glandular and EpithelialCystadenocarcinoma, SerousPregnancy, TubalPeritoneal NeoplasmsHysterosalpingographySalpingitisGenes, BRCA1CA-125 AntigenSterilization, TubalSalpingectomyPregnancy, EctopicGenes, BRCA2Torsion AbnormalityCarcinoma, EndometrioidCystadenoma, SerousCarcinomaAdenocarcinoma, Clear CellInfertility, FemaleCell Line, TumorEarly Detection of CancerGene Expression Regulation, NeoplasticDrug Resistance, NeoplasmPaclitaxelBRCA2 ProteinPelvic NeoplasmsTumor Markers, BiologicalBreast NeoplasmsPollen TubeBRCA1 ProteinNeoplasm StagingOvaryGenital Neoplasms, FemaleImmunohistochemistryGenitalia, FemaleAntineoplastic AgentsMice, NudeCarboplatinCiliaNeoplasm InvasivenessPrognosisNeoplasm ProteinsReverse Transcriptase Polymerase Chain ReactionNeural Tube DefectsCisplatinEpithelial CellsAntineoplastic Combined Chemotherapy ProtocolsGenetic Predisposition to DiseaseEpitheliumGerm-Line MutationRNA, MessengerEndometrial NeoplasmsAdenocarcinoma, PapillaryMutationUrogenital Surgical ProceduresCystadenocarcinoma, MucinousMenstrual CycleAdenocarcinoma, MucinousProlapseNeoplasm Recurrence, LocalProstatic NeoplasmsGynecologic Surgical ProceduresNeoplasm MetastasisSurvival AnalysisAscitesGene Expression ProfilingXenograft Model Antitumor AssaysRetrospective StudiesNeural TubeLung NeoplasmsHysterectomyCell ProliferationPregnancyBlotting, WesternNeoplasmsMifepristoneDisease-Free SurvivalProspective StudiesMycoplasmataceaeSurvival RateColonic NeoplasmsTumor Suppressor Protein p53Hormone AntagonistsFollow-Up StudiesStomach NeoplasmsCell Transformation, NeoplasticEndometriumPelvic Inflammatory DiseaseTreatment OutcomeNeoplasms, Multiple PrimaryTumor Cells, CulturedAntineoplastic Agents, PhytogenicEpididymal Secretory ProteinsDisease ProgressionSensitivity and SpecificityCystadenocarcinoma